HomeSPH • WSE
add
Sopharma AD
Previous close
zł 13.35
Year range
zł 10.70 - zł 18.90
Avg Volume
167.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(BGN) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 503.24M | 12.61% |
Operating expense | 96.04M | 30.15% |
Net income | 17.47M | 439.57% |
Net profit margin | 3.47 | 381.94% |
Earnings per share | — | — |
EBITDA | 21.99M | -28.09% |
Effective tax rate | 14.49% | — |
Balance Sheet
Total assets
Total liabilities
(BGN) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 128.88M | 549.12% |
Total assets | 1.51B | 20.41% |
Total liabilities | 757.08M | 40.89% |
Total equity | 752.81M | — |
Shares outstanding | 159.11M | — |
Price to book | 2.88 | — |
Return on assets | 2.35% | — |
Return on capital | 3.09% | — |
Cash Flow
Net change in cash
(BGN) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 17.47M | 439.57% |
Cash from operations | 115.66M | 57.52% |
Cash from investing | -16.61M | 56.32% |
Cash from financing | 12.41M | 137.13% |
Net change in cash | 111.46M | 5,529.29% |
Free cash flow | 168.09M | 171.67% |
About
Founded
1933
Website
Employees
4,721